Cart is empty The U.S. Food and Drug Administration has approved SpringWorks Therapeutics Inc.’s Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment.
The U.S. Food and Drug Administration has approved SpringWorks Therapeutics Inc.’s Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment.
Leave A Comment